CORC

浏览/检索结果: 共4条,第1-4条 帮助

已选(0)清除 条数/页:   排序方式:
Elevated levels of pre-treatment lactate dehydrogenase are an unfavorable predictor factor in patients with EML4-ALK rearrangement non-small cell lung cancer treated with crizotinib 期刊论文
2019, 卷号: 11, 页码: 8191-8200
作者:  Liang Hongge;  Ma Di;  Xu Yan;  Zhao Jing;  Chen Minjiang
收藏  |  浏览/下载:28/0  |  提交时间:2020/01/03
A case of lung adenocarcinoma with a concurrent EGFR mutation and ALK rearrangement: A case report and literature review 期刊论文
MOLECULAR MEDICINE REPORTS, 2015, 卷号: 12, 期号: [db:dc_citation_issue], 页码: 4370-4375
作者:  Xu, Chun-Wei;  Cai, Xue-Ying;  Shao, Yuan;  Li, Yang;  Shi, Ming-Wei
收藏  |  浏览/下载:4/0  |  提交时间:2019/12/02
HIP1-ALK, A Novel ALK Fusion Variant that Responds to Crizotinib 期刊论文
JOURNAL OF THORACIC ONCOLOGY, 2014, 卷号: 9, 期号: 3
作者:  Fang, Douglas D.;  Zhang, Bin;  Gu, Qingyang;  Lira, Maruja;  Xu, Qiang
收藏  |  浏览/下载:5/0  |  提交时间:2019/12/19
Analysis of clinicopathological features of the echinoderm microtubule-associated protein-like-4-anaplastic lymphoma kinase fusion gene in Chinese patients with advanced non-small-cell lung cancer 期刊论文
2014, 卷号: 5, 期号: 3, 页码: 255-260
作者:  Liu, Yu-Tao;  Shi, Yuan-Kai;  Hao, Xue-Zhi;  Wang, Lin;  Li, Jun-Ling
收藏  |  浏览/下载:2/0  |  提交时间:2020/01/13


©版权所有 ©2017 CSpace - Powered by CSpace